Liposome-encapsulated ISMN: A novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Jardeleza, Camille ^a   Rao, Shasha ^b   Thierry, Benjamin ^b   Gajjar, Pratik ^b   Vreugde, Sarah ^a   Prestidge, Clive A ^b   Wormald, Peter John ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE MONONITRATE; LIPID; LIPOSOME; NITRIC OXIDE; ISOSORBIDE DINITRATE;

ARTICLE; BACTERIAL GROWTH; BIOFILM; COMPUTER PROGRAM; COMSTAT2; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; STAPHYLOCOCCUS AUREUS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; STAPHYLOCOCCAL INFECTIONS;

BIOFILMS; ISOSORBIDE DINITRATE; LIPOSOMES; NITRIC OXIDE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84899089148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092117     Document Type: Article

References (46)

1. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, et al. (2008) Biofilms in chronic wounds. Wound Repair Regen 16: 37-44.
2. Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Munoz-Planillo R, et al. (2013) Staphylococcus delta-toxin induces allergic skin disease by activating mast cells. Nature 503: 397-401.
3. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52: 13-22.
4. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
5. Kluytmans JA, Wertheim HF (2005) Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33: 3-8. (Pubitemid 40585492)
6. Gotz F (2002) Staphylococcus and biofilms. Mol Microbiol 43: 1367-1378.
7. Singhal D, Foreman A, Bardy JJ, Wormald PJ (2011) Staphylococcus aureus biofilms: Nemesis of endoscopic sinus surgery. Laryngoscope 121: 1578-1583.
8. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322. (Pubitemid 29289651)
9. Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW (2008) In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118: 535-540. (Pubitemid 351640625)
10. Foreman A, Psaltis AJ, Tan LW, Wormald PJ (2009) Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 23: 556-561.
11. Foreman A, Wormald PJ (2010) Different biofilms, different disease? A clinical outcomes study. Laryngoscope 120: 1701-1706.
12. Jervis-Bardy J, Foreman A, Field J, Wormald PJ (2009) Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery. Am J Rhinol Allergy 23: 549-552.
13. Lundberg JO (2008) Nitric oxide and the paranasal sinuses. Anat Rec (Hoboken) 291: 1479-1484.
14. Lindberg S, Cervin A, Runer T (1997) Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Oto-Laryngologica 117: 113-117. (Pubitemid 27077016)
15. Degano B, Genestal M, Serrano E, Rami J, Arnal JF (2005) Effect of treatment on maxillary sinus and nasal nitric oxide concentrations in patients with nosocomial maxillary sinusitis. Chest 128: 1699-1705. (Pubitemid 41324466)
16. Deja M, Busch T, Bachmann S, Riskowski K, Campean V, et al. (2003) Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med 168: 281-286. (Pubitemid 36969878)
17. Lundberg JO, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, et al. (1995) High nitric oxide production in human paranasal sinuses. Nat Med 1: 370-373.
18. Runer T, Cervin A, Lindberg S, Uddman R (1998) Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg 119: 278-287. (Pubitemid 28425614)
19. Barraud N, Storey MV, Moore ZP, Webb JS, Rice SA, et al. (2009) Nitric oxide-mediated dispersal in single- and multi-species biofilms of clinically and industrially relevant microorganisms. Microb Biotechnol 2: 370-378.
20. Hetrick EM, Shin JH, Paul HS, Schoenfisch MH (2009) Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 30: 2782-2789.
21. Jardeleza C, Foreman A, Baker L, Paramasivan S, Field J, et al. (2011) The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis. Int Forum Allergy Rhinol 1: 438-444.
22. Chrysant SG, Glasser SP, Bittar N, Shahidi FE, Danisa K, et al. (1993) Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris. Am J Cardiol 72: 1249-1256. (Pubitemid 23357785)
23. (1995) ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345: 669-685.
24. Torchilin VP (2005) Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160.
25. Lian T, Ho RJ (2001) Trends and developments in liposome drug delivery systems. J Pharm Sci 90: 667-680. (Pubitemid 32530443)
26. Huh AJ, Kwon YJ (2011) "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156: 128-145.
27. Smith AW (2005) Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 57: 1539-1550.
28. Campanha MT, Mamizuka EM, Carmona-Ribeiro AM (1999) Interactions between cationic liposomes and bacteria: the physical-chemistry of the bactericidal action. J Lipid Res 40: 1495-1500. (Pubitemid 29379990)
29. Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, et al. (2012) Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori. Mol Pharm 9: 2677-2685.
30. Huang CM, Chen CH, Pornpattananangkul D, Zhang L, Chan M, et al. (2011) Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 32: 214-221.
31. Samadikhah H, Majidi A, Nikkhah M, Hosseinkhani S (2011) Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes. Int J Nanomedicine 6: 2275-2283.
32. Chaturvedi R, Asim M, Lewis ND, Algood HM, Cover TL, et al. (2007) L-arginine availability regulates inducible nitric oxide synthase-dependent host defense against Helicobacter pylori. Infect Immun 75: 4305-4315. (Pubitemid 47378087)
33. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, et al. (2000) Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146 (Pt 10): 2395-2407.
34. Cunha BA, Gill MV, Lazar JM (1996) Acute infective endocarditis. Diagnostic and therapeutic approach. Infect Dis Clin North Am 10: 811-834.
35. Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350: 1422-1429.
36. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, Kirby A, Tilley R, et al. (2011) Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis 11: 208-222.
37. Maherani B, Arab-Tehrany E, R Mozafari M, Gaiani C, Linder M (2011) Liposomes: a review of manufacturing techniques and targeting strategies. Curr Nanosci 7: 436-452.
38. Kim H-J, Michael Gias EL, Jones MN (1999) The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids and Surfaces A: Physicochemical and Engineering Aspects 149: 561-570. (Pubitemid 29132720)
39. Kilty SJ, Desrosiers MY (2008) The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis. Curr Allergy Asthma Rep 8: 227-233.
40. Habimana O, Steenkeste K, Fontaine-Aupart MP, Bellon-Fontaine MN, Kulakauskas S, et al. (2011) Diffusion of nanoparticles in biofilms is altered by bacterial cell wall hydrophobicity. Appl Environ Microbiol 77: 367-368.
41. Jones MN (2005) Use of liposomes to deliver bactericides to bacterial biofilms. Methods Enzymol 391: 211-228.
42. Meng J, Wang H, Hou Z, Chen T, Fu J, et al. (2009) Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother 53: 2871-2878.
43. Peulen TO, Wilkinson KJ (2011) Diffusion of nanoparticles in a biofilm. Environ Sci Technol 45: 3367-3373.
44. Baek YW, An YJ (2011) Microbial toxicity of metal oxide nanoparticles (CuO, NiO, ZnO, and Sb2O3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci Total Environ 409: 1603-1608.
45. Hajipour MJ, Fromm KM, Ashkarran AA, Jimenez de Aberasturi D, de Larramendi IR, et al. (2012) Antibacterial properties of nanoparticles. Trends Biotechnol 30: 499-511.
46. Bradley JS, Guidos R, Baragona S, Bartlett JG, Rubinstein E, et al. (2007) Anti-infective research and development-problems, challenges, and solutions. Lancet Infect Dis 7: 68-78. (Pubitemid 44917784)